{"id":3655,"date":"2018-11-21T17:47:28","date_gmt":"2018-11-21T12:17:28","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=3655"},"modified":"2021-07-24T12:57:08","modified_gmt":"2021-07-24T07:27:08","slug":"newsletter-3","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/newsletter-3","title":{"rendered":"Newsletter"},"content":{"rendered":"![\"newsletter\"](\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/15171836\/Screenshot-25.png\")
<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17126],"tags":[17684,17685,3011],"industry":[17225],"therapeutic_areas":[17239,17278],"class_list":["post-3655","post","type-post","status-publish","format-standard","hentry","category-others","tag-aries-pharmaceuticals","tag-cosmo-pharmaceuticals","tag-travelers-diarrhea","industry-pharmaceutical","therapeutic_areas-gastroenterology","therapeutic_areas-other-diseases"],"acf":[],"yoast_head":"\n
Newsletter - DelveInsight Business Research<\/title>\n<meta name=\"description\" content=\"Bewsletter on FDA's approval for Amecolo..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newsletter - DelveInsight Business Research\" \/>\n<meta property=\"og:description\" content=\"Bewsletter on FDA's approval for Amecolo..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-21T12:17:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:27:08+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/Screenshot-25.png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Newsletter - DelveInsight Business Research","description":"Bewsletter on FDA's approval for Amecolo..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/","og_locale":"en_US","og_type":"article","og_title":"Newsletter - DelveInsight Business Research","og_description":"Bewsletter on FDA's approval for Amecolo..","og_url":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2018-11-21T12:17:28+00:00","article_modified_time":"2021-07-24T07:27:08+00:00","og_image":[{"url":"http:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/Screenshot-25.png","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/newsletter-3","url":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/","name":"Newsletter - DelveInsight Business Research","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/#primaryimage"},"thumbnailUrl":"http:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/Screenshot-25.png","datePublished":"2018-11-21T12:17:28+00:00","dateModified":"2021-07-24T07:27:08+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Bewsletter on FDA's approval for Amecolo..","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/newsletter-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/newsletter-3\/#primaryimage","url":"http:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/Screenshot-25.png","contentUrl":"http:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2018\/11\/Screenshot-25.png"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/others\/\" class=\"advgb-post-tax-term\">Others<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Others<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/others\/\" class=\"advgb-post-tax-term\">Aries Pharmaceuticals<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/others\/\" class=\"advgb-post-tax-term\">Cosmo Pharmaceuticals<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/others\/\" class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Aries Pharmaceuticals<\/span>","<span class=\"advgb-post-tax-term\">Cosmo Pharmaceuticals<\/span>","<span class=\"advgb-post-tax-term\">Traveler\u2019s diarrhea<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Nov 21, 2018","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Nov 21, 2018 5:47 pm","modified":"Updated on Jul 24, 2021 12:57 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=3655"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/3655\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=3655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=3655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=3655"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=3655"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=3655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}